早期非小细胞肺癌立体定向放疗的相关研究

doi:10.11904/j.issn.1002-3070.2018.01.010

摘要/Abstract

摘要： 目前临床上确诊的早期非小细胞肺癌患者中,约20%因自身原因不能手术。立体定向放射治疗具有治疗时间短、治疗相关性损伤轻及肿瘤局控率高的优势,当前国际上已经将其作为早期不能手术非小细胞肺癌的一线治疗方案。在早期能手术非小细胞肺癌的治疗中,立体定向放疗也达到了令人鼓舞的治疗效果,但也存在部分亟待解决的问题。本文将对立体定向放射治疗在早期非小细胞肺癌治疗中的剂量分割、临床适应症及放疗损伤进行综述。

关键词: 立体定向放射治疗, 早期, 非小细胞肺癌, 周围型, 中央型

Abstract: At present,approximately 20% of patients with clinically diagnosed early non-small cell lung cancer(NSCLC)are inoperable for their own reasons.Stereotactic radiotherapy(SRT)has the advantages of short treatment time,mild treatment-related injury and high local control rate.Currently,it has been used internationally as a first-line treatment for early incapacity of NSCLC.SRT has also achieved encouraging therapeutic effects in the treatment of early-stage NSCLC,but there are also some problems to be solved urgently.This article aims to summarize the dosimetry,clinical indications and radiotherapy injury of SRT in the treatment of early-stage NSCLC.

Key words: Stereotactic radiotherapy, Early-stage, Non-small cell lung cancer, Peripheral, Central

中图分类号:

R734.2

孙明亮, 徐建宇, 徐向英. 早期非小细胞肺癌立体定向放疗的相关研究[J]. 实用肿瘤学杂志, 2018, 32(1): 53-56.

SUN Mingliang, XU Jianyu, XU Xiangying. Stereotactic radiotherapy for early stage of non - small cell lung cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 53-56.

参考文献

1 徐向英,曲雅勤,伍刚,等.肿瘤放射治疗学[M].北京:人民卫生出版社,2017:190.
2 Shaverdian N,Wang PC,Steinberg M,et al.The patient′s perspective on stereotactic body radiation therapy vs. surgery for treatment of early stage non-small cell lung cancer[J].Lung Cancer,2015,90(2):230-233.
3 Turzer M,Brustugun OT,Waldeland E,et al.Stereotactic body radiation therapy is effective and safe in patients with early-stage non-small cell lung cancer with low performance status and severe comorbidity[J].Case Rep Oncol,2011,4(1):25-34.
4 Timmerman RD,Park C,Kavanagh BD,et al.The North American experience with stereotactic body radiation therapy in non-small cell lung cancer[J].J Thorac Oncol,2007,2(7):101-112.
5 Ueki N,Matsuo Y,Shibuya K,et al.Differences in the dose-volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer[J].J Radiat Res,2012,54(2):337-343.
6 Onishi H,Araki T.Stereotactic body radiation therapy for stage I non-small-cell lung cancer:A historical overview of clinical studies[J].Jpn J Clin Oncol,2013,43(4):345-350.
7 Factor OB,Vu CC,Schneider JG,et al.Stereotactic body radiation therapy for stage I non-small cell lung cancer:A small academic hospital experience[J].Front Oncol,2014,4:287-298.
8 Janssen-Heijnen MLG,Maas HAAM,Houterman S,et al.Comorbidity in older surgical cancer patients:Influence on patient care and outcome[J].Eur J Cancer,2007,43(15):2179-2193.
9 Lagerwaard FJ,Verstegen NE,Haasbeek CJA,et al.Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer[J].Int J Radiat Oncol Biol Phys,2012,83(1):348-353.
10 Lischalk JW,Woo SM,Kataria S,et al.Long-term outcomes of stereotactic body radiation therapy with fiducial tracking for in operable stage I non-small cell lung cancer[J].J Radiat Oncol,2016,5(4):379-387.
11 Taremi M,Hope A,Dahele M,et al.Stereotactic body radiotherapy for medically inoperable lung cancer:prospective,single-center study of 108 consecutive patients[J].Int J Radiat Oncol Biol Phys,2012,82(2):967-973.
12 夏廷毅,李宏奇,王颖杰,等.全身γ刀治疗不能手术Ⅰ和Ⅱ期非小细胞肺癌的临床结果[J].中华放射肿瘤学杂志,2007,16(2):91-97.
13 Dunlap NE,Larner JM,Read PW,et al.Size matters:a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy[J].J Thorac Cardiovasc Surg,2010,140(3):583-589.
14 Ricardi U,Frezza G,Filippi AR,et al.Stereotactic ablative radiotherapy for stage I histologically proven non-small cell lung cancer:an Italian multicenter observational study[J].Lung Cancer,2014,84(3):248-253.
15 Haasbeek CJ,Lagerwaard FJ,Slotman BJ,et al.Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer[J].J Thorac Oncol,2011,6(12):2036-2043.
16 Fakiris AJ,Mcgarry RC,Yiannoutsos CT,et al.Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma:four-year results of a prospective phase II study[J].Int J Radiat Oncol Biol Phys,2009,75(3):677-682.
17 Davis JN,Medbery C,Sharma S,et al.Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the research patient registry[J].Radiat Oncol,2015,10(1):113-114.
18 Modh A,Rimner A,Williams E,et al.Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy[J].Int J Radiat Oncol Biol Phys,2014,90(5):1168-1176.
19 Wang P,Zhang D,Guo XG,et al.A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly:[J].Medicine,2016,95(52):127-132.
20 Port J L,Parashar B,Osakwe N,et al.A propensity-matched analysis of wedge resection and stereotactic body radiotherapy for early stage lung cancer[J].Ann Thorac Surg,2014,98(4):1152-1159.
21 Chang JY,Senan S,Paul MA,et al.Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer:a pooled analysis of two randomised trials[J].Lancet Oncol,2015,16(6):630-637.
22 王建东,左占杰,张洪波,等.电视辅助胸腔镜手术和体部立体定向放疗治疗早期非小细胞肺癌的临床疗效比较[J].中国肺癌杂志,2016,19(3):136-146.
23 Sun B,Brooks ED,Komaki RU,et al.7‐year follow-up after stereotactic ablative radiotherapy for patients with stage I non‐small cell lung cancer:Results of a phase 2 clinical trial[J].Cancer,2017,123(16):3031-3039.
24 王烽,田锋,佟玉筠,等.PET-CT在周围型非小细胞肺癌N分期及淋巴结清扫中的价值[J].中华临床医师杂志(电子版),2013,7(2):609-612.
25 Nambu A,Onishi H,Aoki S,et al.Rib fracture after stereotactic radiotherapy on follow-up thin-section computed tomography in 177 primary lung cancer patients[J].Radiat Oncol,2011,6(1):1-9.
26 Jumeau R,Filion ,Bahig H,et al.A dosimetric parameter to limit chest wall toxicity in SABR of NSCLC[J].Br J Radiol,2017,90(1075):196-197.
27 Nishimura S,Takeda A,Sanuki N,et al.Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors[J].J Thorac Oncol,2014,9(9):1370-1376.
28 Stauder MC,Macdonald OK,Olivier KR,et al.Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions[J].Radiother Oncol,2011,99(2):166-171.
29 Li Q,Swanick CW,Allen PK,et al.Stereotactic ablative radiotherapy(SABR)using 70 Gy in 10 fractions for non-small cell lung cancer:exploration of clinical indications[J].Radiother Oncol,2014,112(2):256-261.
30 Mou B,Merrell KW,Owen DA,et al.Stereotactic body radiation therapy for central lung tumors:outcomes and toxicity:treatment toxicity[J].Int J Radiat Oncol Biol Phys,2014,90(5):80-81.

[1]	孙立春,李丹丹,李净,于凤玲. CCDC8和TGF-β1在非小细胞肺癌中的表达及临床意义[J]. 实用肿瘤学杂志, 2019, 33(3): 215-221.
[2]	刘仲阳, 袁欣, 周文, 李晓亮, 樊立茂. 微创小切口手术对早期胸中下段食管癌患者的治疗效果及对其疼痛的影响[J]. 实用肿瘤学杂志, 2019, 33(1): 57-61.
[3]	李万祯, 殷俊, 李萍, 林晓辉, 张国前, 张书旭. iR-17在非小细胞肺癌放射抗拒细胞中的表达及作用研究[J]. 实用肿瘤学杂志, 2018, 32(5): 391-397.
[4]	蔡静, 候玥. 非小细胞肺癌患者血清miR-195的表达及其临床意义[J]. 实用肿瘤学杂志, 2018, 32(5): 415-419.
[5]	崔晓燕, 涂青, 甘建辉. 纳布啡与羟考酮自控镇痛对非小细胞肺癌患者术后免疫因子水平影响的比较[J]. 实用肿瘤学杂志, 2018, 32(4): 309-314.
[6]	雷俊华, 许冠华, 曾江正, 黄芬, 何志惠, 卢彦达. 隐丹参酮联合顺铂抗非小细胞肺癌NCI-H1975细胞JAK2/STAT3机制研究[J]. 实用肿瘤学杂志, 2018, 32(3): 198-202.
[7]	翟可可, 高媛媛, 冯晓, 许静文, 宫玉芳, 孟庆威. 术后辅助化疗后复发转移与初次诊断的IV期NSCLC一线化疗疗效分析[J]. 实用肿瘤学杂志, 2018, 32(2): 107-111.
[8]	杜夜生, 胡松柳, 徐向英. 非小细胞肺癌寡转移的立体定向放射治疗研究[J]. 实用肿瘤学杂志, 2018, 32(2): 154-158.
[9]	代欣综述, 张大昕审校. 非小细胞肺癌抗血管生成治疗研究现状[J]. 实用肿瘤学杂志, 2017, 31(5): 472-476.
[10]	胡海峰, 冯谢敏, 乔健, 段伟, 刘宁宁, 孙晓东. miR-345在非小细胞肺癌中的表达及临床意义[J]. 实用肿瘤学杂志, 2017, 31(2): 117-122.
[11]	陈子印, 钱茂森, 潘慧莹. 非共面野在早期非小细胞肺癌立体定向放射治疗方面的剂量学优势[J]. 实用肿瘤学杂志, 2017, 31(2): 142-146.
[12]	张锐，王智煜，王帅，赵晖. 重组人血管内皮抑素联合NP方案治疗初诊晚期非小细胞肺癌骨转移疗效及对血清VEGF表达的影响[J]. 实用肿瘤学杂志, 2016, 30(6): 527-522.
[13]	徐俊, 张恩勇, 罗天航, 薛绪潮, 崔航天, 方国恩. 早期胃混合型印戒细胞癌的临床病理因素分析[J]. 实用肿瘤学杂志, 2016, 30(5): 414-419.
[14]	任凤海,王丹丹,王俊峰,徐海,徐世东. 单孔与单操作孔电视辅助胸腔镜手术治疗ⅠA期非小细胞肺癌的临床对比研究[J]. 实用肿瘤学杂志, 2016, 30(4): 327-331.
[15]	叶磊光, 闫安, 刘宝刚. Aurora-A参与非小细胞肺癌化疗药耐药与患者预后的关系[J]. 实用肿瘤学杂志, 2016, 30(2): 97-102.